707 related articles for article (PubMed ID: 17970611)
1. AMCP Guide to Pharmaceutical Payment Methods.
AMCP Task Force on Drug Payment Methodologies
J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
[TBL] [Abstract][Full Text] [Related]
2. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
Academy of Managed Care Pharmacy
J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
[TBL] [Abstract][Full Text] [Related]
3. The distributional implications of using relative prices in DRG payment systems.
Thorpe KE
Inquiry; 1987; 24(1):85-95. PubMed ID: 2951338
[TBL] [Abstract][Full Text] [Related]
4. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
[TBL] [Abstract][Full Text] [Related]
5. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider administrative appeals and judicial review; enforcement provisions for organ transplant centers; and electronic health record (EHR) incentive program. Final rule.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2014 Aug; 79(163):49853-50536. PubMed ID: 25167590
[TBL] [Abstract][Full Text] [Related]
6. Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services; Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(157):50041-681. PubMed ID: 20712087
[TBL] [Abstract][Full Text] [Related]
7. Saga of payment systems of ambulatory surgery centers for interventional techniques: an update.
Manchikanti L; Singh V; Hirsch JA
Pain Physician; 2012; 15(2):109-30. PubMed ID: 22430649
[TBL] [Abstract][Full Text] [Related]
8. Physician payment 2008 for interventionalists: current state of health care policy.
Manchikanti L; Giordano J
Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
Seay M
Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
[TBL] [Abstract][Full Text] [Related]
10. Recommendations of the Medicare Payment Advisory Commission (MEDPAC) on the Health Care Delivery System: the impact on interventional pain management in 2014 and beyond.
Manchikanti L; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2013; 16(5):419-40. PubMed ID: 24077189
[TBL] [Abstract][Full Text] [Related]
11. Physician payment outlook for 2012: déjà vu.
Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
[TBL] [Abstract][Full Text] [Related]
12. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
13. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
[TBL] [Abstract][Full Text] [Related]
14. Medicare program; changes to Medicare payment for drugs and physician fee schedule payments for calendar year 2004. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2004 Jan; 69(4):1083-267. PubMed ID: 14968797
[TBL] [Abstract][Full Text] [Related]
15. Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment rates; and payments for graduate medical education for affiliated teaching hospitals in certain emergency situations Medicare and Medicaid programs: hospital conditions of participation; necessary provider designations of critical access hospitals. Interim and final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2007 Nov; 72(227):66579-7226. PubMed ID: 18044033
[TBL] [Abstract][Full Text] [Related]
16. A review of prescription pricing and a call for equitable payment.
Grapes ZT; Brown TR
Hospitals; 1976 Jul; 50(13):91-2, 96, 98. PubMed ID: 1278895
[TBL] [Abstract][Full Text] [Related]
17. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2009 Aug; 74(165):43753-4236. PubMed ID: 19827228
[TBL] [Abstract][Full Text] [Related]
18. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditions of participation; payment policies related to patient status. Final rules.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2013 Aug; 78(160):50495-1040. PubMed ID: 23977713
[TBL] [Abstract][Full Text] [Related]
19. AMCP Partnership Forum: Advancing Value-Based Contracting.
J Manag Care Spec Pharm; 2017 Nov; 23(11):1096-1102. PubMed ID: 29083973
[TBL] [Abstract][Full Text] [Related]
20. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.
Mullins CD; Seal B; Seoane-Vazquez E; Sankaranarayanan J; Asche CV; Jayadevappa R; Lee WC; Romanus DK; Wang J; Hay JW; Smeeding J
Value Health; 2010; 13(1):18-24. PubMed ID: 19807903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
